Incidence of Psoriatic Arthritis Among Psoriasis Patients Newly Initiated With Secukinumab in a US Claims Database and a UK Registry
Clinical trial NCT06172426 · COMPLETED
Trial details
- NCT number
- NCT06172426
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-11-17
- Primary completion
- 2022-12-07
- Enrollment
- 1171
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.